Dr. Josh Sharan graduated with multiple honors recognitions from Nova Southeastern University’s College of Osteopathic Medicine. He has performed extensive research in the field of regenerative medicine, describing in literature multiple first in human responses to mesenchymal stem cell therapy for various orthopedic and autoimmune conditions. Much of his work has been presented at the International Cartilage Regeneration Society conference and published in peer reviewed journals. Dr. Sharan is a cofounder of Opris Biotechnologies and Florida Biotechnologies, both of which are focused on therapeutics for rare pediatric diseases. Dr. Sharan leads the preclinical and clinical development of Camelot BioCapital’s pipeline.
